CHM 10.0% 0.9¢ chimeric therapeutics limited

Charting Only, page-173

  1. 336 Posts.
    lightbulb Created with Sketch. 27
    Hard to say that a CR is imminent.

    In any case - good management what have never allowed this situation to occur.

    Relentless selling occurs when there's concerns about the businesses going concern irrespective of the pipeline.

    The strategy of building brand awareness around Chimeric also has been lackluster - those flat videos with the Finance News Network really need to go.

    I have to agree with a comments made previously on management buying stock. They have to show leadership - and skin in the game.


 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.